S'abonner

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study - 31/01/18

Doi : 10.1016/j.jinf.2017.11.006 
Nicole E. Basta a, * , Abdoulaye Berthe b, Mahamadou Keita b, Uma Onwuchekwa b, Boubou Tamboura b, Awa Traore b, Musa Hassan-King c, Olivier Manigart b, c, Maria Nascimento c, James M. Stuart c, Caroline Trotter d, Jayne Blake e, Anthony D. Carr e, Stephen J. Gray e, Lynne S. Newbold e, Yangqing Deng f, Julian Wolfson f, M. Elizabeth Halloran g, h, Brian Greenwood c, Ray Borrow e, Samba O. Sow b
a Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454, USA 
b Centre pour les Vaccins en Developpement-Mali, Centre National d'Appui a la lutte contre la Maladie (CNAM) Ministère de la Santé, Ex-Institut Marchoux, BP 251, Bamako, Mali 
c London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom 
d Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, United Kingdom 
e Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, M13 9WL, United Kingdom 
f Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454, USA 
g Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA 
h Department of Biostatistics, University of Washington, Seattle, Washington 98195, USA 

*Corresponding author. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 Second Street South, West Bank Office Building Suite 300, Minneapolis, MN 55454, USA.Division of Epidemiology and Community HealthSchool of Public HealthUniversity of Minnesota1300 Second Street South, West Bank Office Building Suite 300MinneapolisMN55454USA

Highlights

We demonstrated the feasibility of conducting a longitudinal, household-based study of meningococcal carriage in the African meningitis belt.
During the cross-sectional screening visit, the carriage prevalence was 5% (20 carriers among 400 participants from 116 households).
Over 17 months, 1422 swabs were obtained from 202 people in 20 households. 73 carrier isolates identified; 33 people (16.3%) carried at least once.
Among all swabs collected, 84% of isolates were non-groupable, though 6 W and 9 Y isolates were identified. No A, C, or X carriers were found.
The meningococcal carriage duration, any serogroup, was 2.9 months (95% CI: 1.6, 5.4). The acquisition rate was 2.3% per month (95% CI: 1.3, 3.8).

Le texte complet de cet article est disponible en PDF.

Summary

Objectives

Carriers of Neisseria meningitidis are a key source of transmission. In the African meningitis belt, where risk of meningococcal disease is highest, a greater understanding of meningococcal carriage dynamics is needed.

Methods

We randomly selected an age-stratified sample of 400 residents from 116 households in Bamako, Mali, and collected pharyngeal swabs in May 2010. A month later, we enrolled all 202 residents of 20 of these households (6 with known carriers) and collected swabs monthly for 6 months prior to MenAfriVac vaccine introduction and returned 10 months later to collect swabs monthly for 3 months. We used standard bacteriological methods to identify N. meningitidis carriers and fit hidden Markov models to assess acquisition and clearance overall and by sex and age.

Results

During the cross-sectional study 5.0% of individuals (20/400) were carriers. During the longitudinal study, 73 carriage events were identified from 1422 swabs analyzed, and 16.3% of individuals (33/202) were identified as carriers at least once. The majority of isolates were non-groupable; no serogroup A carriers were identified.

Conclusions

Our results suggest that the duration of carriage with any N. meningitidis averages 2.9 months and that males and children acquire and lose carriage more frequently in an urban setting in Mali. Our study informed the design of a larger study implemented in seven countries of the African meningitis belt.

Le texte complet de cet article est disponible en PDF.

Keywords : Bacterial Meningitis, Meningococcal disease, Neisseria meningitidis, Carriers, Africa, Mali, Epidemiology


Plan


© 2017  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 76 - N° 2

P. 140-148 - février 2018 Retour au numéro
Article précédent Article précédent
  • A daily topical decontamination regimen reduces catheter-related bloodstream infections in haematology patients
  • Clare Samuelson, Harpreet Kaur, Evangelos I. Kritsotakis, Stephen D. Goode, Aileen Nield, David Partridge
| Article suivant Article suivant
  • Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France
  • Eva Hong, Anne-Sophie Barret, Aude Terrade, Mélanie Denizon, Denise Antona, Myriam Aouiti-Trabelsi, Ala-Eddine Deghmane, Isabelle Parent du Châtelet, Daniel Levy-Bruhl, Muhamed-Kheir Taha

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.